Hartford Financial Management »

Celldex Therapeutics shares owned by Hartford Financial Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Hartford Financial Management from 13F filings

Historical chart of Hartford Financial Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Hartford Financial Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Hartford Financial Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $756 18 42.00
2023-12-31 $714 18 39.67
2023-09-30 $496 18 27.56
2023-06-30 $610 18 33.94
2023-03-31 $648 18 36.00
2022-12-31 $802 18 44.56
2022-09-30 $1.0k 18 55.56
2022-03-31 $1.0k 18 55.56
2021-12-31 $1.0k 18 55.56
2021-09-30 $1.0k 18 55.56
2021-06-30 $1.0k 18 55.56

More positions owned by Hartford Financial Management

J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
First Tr Exchng Traded Fd Vi Ft Vest U.s. (DAUG)
JPMorgan Chase & Co. (JPM)
Costco Wholesale Corporation (COST)
Apple (AAPL)
J P Morgan Exchange Traded F Municipal Etf (JMUB)
CSX Corporation (CSX)
Caterpillar (CAT)
Home Depot (HD)
Waste Management (WM)
First Tr Exchng Traded Fd Vi Ft Vest U.s. (DAPR)
J P Morgan Exchange Traded F Diversfd Eqt Etf (JPSE)
Applied Materials (AMAT)

View all positions for Hartford Financial Management

Top funds holding Celldex Therapeutics

Wellington Management Company
Eventide Asset Management
Vanguard Group
Kynam Capital Management
Point72 Asset Management
Bellevue Group
Marshall Wace
Redmile Group
Octagon Capital Advisors
Commodore Capital
Jennison Associates
Charles Schwab Investment Management
5AM Venture Management
Goldman Sachs Group
Sphera Funds Management

View all funds holding Celldex Therapeutics